November 17, 2010 | Filed under: News,Video | Posted by:
An experimental drug by Merck that pushed the so-called good cholesterol to off-the-charts levels while also dropping bad cholesterol is renewing hopes for a novel way to lower heart risks. (Nov. 17)
Posted by
on November 17, 2010. Filed under News, Video.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry